Skip to content

KTTA

Pasithea Therapeutics Corp.

NASDAQ · Healthcare · Biotechnology · US

$0.52
+3.36%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.21
Revenue estimate
$200.0K

Latest reported

Last report date
Aug 14, 2026
EPS actual
-$0.16
EPS estimate
-$0.16
Revenue actual
Revenue estimate
$300.0K

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
3
EPS in line (12Q)
1
Avg surprise (4Q)
-76.5%
Revenue beats (12Q)
1
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 14, 2026-$0.16-$0.16In line
May 15, 2026-$0.45-$0.12Beat 73.33%
Mar 30, 2026-$0.18-$0.89Miss -394.44%
Nov 13, 2025-$0.41
Aug 14, 2025-$0.66
May 15, 2025-$1.61
Mar 24, 2025-$2.41
Nov 13, 2024-$2.87
Aug 13, 2024-$3.71
Aug 11, 2023-$3.40-$2.88Beat 15.28%
May 12, 2023-$3.40-$211Miss -6107.34%
Nov 14, 2022-$3.40-$3.45Miss -1.61%$218.6K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026